Nirupama (Rupa) Pike, PhD
Articles
From Early Development to Commercialization: Strategies for Successful Cell Therapy Manufacturing
December 23rd 2024Dr Rupa Pike, Sr. Director & Global Head Strategic Alliances and Field Scientists for Cell Therapy, Catalent, shares insight on de-risking cell therapy programs using streamlined development and manufacturing platforms.
Latest Updated Articles
Published: January 10th 2025 | Updated: January 13th 2025
Cavazzoni Retires as CDER Director
Published: October 11th 2024 | Updated: October 18th 2024
Buy, Sell, Hold: Cell and Gene Therapy - Part 1
Published: September 10th 2024 | Updated: September 18th 2024
CPHI Milan Announces 2024 CPHI Pharma Award Finalists
Published: January 2nd 2025 | Updated: February 23rd 2025
Excipient World Conference and Expo: May 12–14, 2025
Published: February 10th 2025 | Updated: February 23rd 2025
Industry Outlook 2025: Experts Weigh in on the Most Impactful Trends for Industry
Published: January 30th 2025 | Updated: February 23rd 2025
Industry Outlook 2025: Shifting Political Landscapes
